Multidrug resistance in human cancer

Critical Reviews in Oncology and Hematology

Volumn 12, Issue 3, 1992, Pages 243-253

  Goldstein, Lori J ^a   Pastan, Ira ^b   Gottesman, Michael M ^b  

^a FOX CHASE CANCER CENTER   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOSPORIN A; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; QUINIDINE; TAMOXIFEN; TRIFLUOPERAZINE; VERAPAMIL; VINBLASTINE; VINCRISTINE;

ADULT; BONE MARROW SUPPRESSION; CANCER; CARDIOTOXICITY; CHEMOTHERAPY; CLINICAL ARTICLE; EXTRAPYRAMIDAL SYNDROME; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; MULTIDRUG RESISTANCE; REVIEW;

ANIMAL; ANTINEOPLASTIC AGENTS; CARRIER PROTEINS; DRUG RESISTANCE; FEASIBILITY STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMAN; MEMBRANE GLYCOPROTEINS; MICE; MICE, TRANSGENIC; NEOPLASM PROTEINS; NEOPLASMS; NEOPLASMS, EXPERIMENTAL; P-GLYCOPROTEIN; TRIFLUOPERAZINE; TUMOR CELLS, CULTURED; VERAPAMIL;

EID: 0026653953     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/1040-8428(92)90057-W     Document Type: Review

References (77)

1. The multidrug transporter, a double edged sword
2. Glutathione S-transferase and drug resistance
3. Pharmacological, molecular, and cytogenetic analysis of ‘atypical’ multidrug-resistant human leukemic cells
4. Cellular resistance to actinomycin D in Chinese hamster ovary cells in vitro: cross-resistance, radiographic and cytogenetic studies
5. Genetics of multidrug resistance
6. The biochemistry of P-glycoprotein-mediated multidrug resistance
7. Genetic basis of multidrug resistance of tumor cells
8. Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells
9. Mammalian multidrug resistance gene: complete cDNA sequence indicates strong homology to bacterial transport proteins
10. Homology between P-glycoprotein and a bacterial haemolysin transport protein suggests a model for multidrug resistance
11. A family of related ATP-binding subunits coupled to many distinct biological processes in bacteria
12. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA
13. Certain calcium channel blockers bind specifically to multidrug-resistant human KB carcinoma membrane vesicles and inhibit drug binding to P-glycoprotein
14. Reduced drug accumulation in multiple drug-resistant human KB carcinoma cell lines
15. Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil
16. Effects of indole alkaloids on multidrug resistance and labeling of P-glycoprotein by a photoaffinity analog of vinblastine
17. Immunocytochemical localization of P170 at the plasma membrane of multidrug-resistant human cells
18. Membrane vesicles from multidrug-resistant human cancer cells contain a specific 150–170 kDa protein detected by photoaffinity labeling
19. Vinblastine photoaffinity labeling of a high molecular weight surface membrane glycoprotein specific for multidrug resistant cells
20. ATP-dependent transport of vinblastine in vesicles from multidrug-resistant cells
21. Isolation and expression of a complementary DNA that confers multidrug resistance
22. Expression of a full-length cDNA for the human MDR1 gene confers resistance to colchicine, doxorubicin and vinblastine
23. Retroviral transfer of a murine cDNA for multidrug resistance confers pleiotropic drug resistance to cells without prior drug selection
24. A retrovirus carrying an MDR1 cDNA confers multidrug resistance and polarized expression of P. glycoprotein in MDCK cells
25. Expression of a human multidrug resistance cDNA (MDR1) in the bone marrow of transgenic mice: resistance to daunomycin-induced leukopenia
26. Transgenic mice which express the human multidrug resistance gene in bone marrow enable a rapid identification of agents which reverse drug resistance
27. Measurement of multidrug resistance messenger RNA in urogenital cancers; elevated expression in renal cell carcinoma is associated with intrinsic drug resistance
28. Intrinsic drug resistance in human kidney cancer is associated with expression of a human multidrug resistance gene
29. Cellular localization of the multidrug resistance gene product P-glycoprotein in normal human tissues
30. Tissue distribution of P-glycoprotein encoded by a multidrug resistant gene as revealed by a monoclonal antibody, MRK16
31. Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein, P170: evidence for localization in brain capillaries and cross-reactivity of one antibody with a muscle protein
32. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites
33. Expression of a multidrug resistance gene in human cancers
34. Expression of a multidrug-resistance gene in human tumors and tissues
35. MDR1 RNA levels in human renal cell carcinomas: Correlation with grade and prediction of reversal of doxorubicin resistance by quinidine in tumor explants
36. Surgical adjuvant therapy of large bowel carcinoma: an evaluation of levamisole and the combination of levamisole and 5-fluorouracil: a study of the North Central Cancer Treatment Group and Mayo Clinic
37. Expression of the multidrug-resistance (MDR1) gene in neuroblastoma
38. Correlation of MDR1 gene expression with chemotherapy in neuroblastoma
39. Detection of a multidrug resistant phenotype in acute non-lymphoblastic leukemia
40. Expression of the mdr-1/P170 gene in patients with acute lymphoblastic leukemia
41. Expression of mdr1 and mdr3 multidrug-resistance genes in human acute and chronic leukemias and association with stimulation of drug accumulation by cyclosporin
42. Evaluation of levamisole as an adjuvant to chemotherapy for treatment of ANLL
43. Expression of the multidrug resistance gene in myeloid leukemias
44. MDR1 transcript levels as an indication of resistant disease in acute nonlymphocytic leukemia
45. MDR1 gene expression and treatment outcome in acute myeloid leukemia
46. Expression of a multidrug resistance gene in blast crisis of chronic myelogenous leukemia
47. Electrophoretic analysis of 248 clinical breast specimens for PGP overexpression or gene amplification
48. MDR1 expression in lung cancer
49. P-glycoprotein expression in treated and untreated human breast cancer
50. Expression of a human multidrug resistance gene in ovarian carcinomas
51. Drug resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy
52. Expression of anionic glutathione S-transferase and P-glycoprotein genes in human tissues and tumors
53. Immunohistochemical detection of P-glycoprotein prognostic correlation in soft tissue sarcoma of childhood
54. Detection of P-glycoprotein in ovarian cancer: a molecular marker associated with drug resistance
55. Incidence of elevated P-glycoprotein in human tumors
56. Taxol a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasm
57. P-glycoprotein in human sarcoma: Evidence for multidrug resistance
58. P-glycoprotein expression in treated and untreated human breast cancer
59. Immunohistochemical analysis of P-glycoprotein expression correlated with chemotherapy resistance in locally advanced breast cancer
60. Distribution of multidrug resistance-associated P-glycoprotein in normal and neoplastic human tissues
61. Clinical relevance of immunohistochemical detection of multidrug resistance P-glycoprotein in breast carcinoma
62. mRNA phenotyping by enzymatic amplification of randomly primed cDNA
63. Use of the polymerase chain reaction in the quantitation of mdr-1 gene expression
64. Optimization of immunocytochemical P-glycoprotein assessment in multidrug-resistant plasma cell myeloma using three antibodies
65. Verapamil and adriamycin in the treatment of drug-resistance ovarian cancer patients
66. Clinical modulation of doxorubicin resistance by the calmodulin inhibitor, trifluoperazine: a phase I/II trial
67. Clinical trial of continuous infusion verapamil, bolus vinblastine, and continuous infusion VP-16 in drug-resistant pediatric tumors
68. Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: Detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy
69. Multidrug-resistant myeloma: laboratory and clinical effects of verapamil as a chemosensitizer
70. Reversal of drug-resistance with cyclosporin-A in a patient with acute myelocytic leukaemia
71. A pilot study of quinidine and epirubicin in the treatment of advanced breast cancer
72. Addition of verapamil and tamoxifen to the initial chemotherapy of small cell lung cancer
73. Altered therapeutic range for quinidine after myocardial infarction and cardiac surgery